These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

224 related items for PubMed ID: 9207819

  • 1. Double-blind, placebo-controlled study of ranitidine for gastroesophageal reflux symptoms during pregnancy.
    Larson JD, Patatanian E, Miner PB, Rayburn WF, Robinson MG.
    Obstet Gynecol; 1997 Jul; 90(1):83-7. PubMed ID: 9207819
    [Abstract] [Full Text] [Related]

  • 2. Clinical effectiveness and quality of life with ranitidine vs placebo in gastroesophageal reflux disease patients: a clinical experience network (CEN) study.
    Rush DR, Stelmach WJ, Young TL, Kirchdoerfer LJ, Scott-Lennox J, Holverson HE, Sabesin SM, Nicholas TA.
    J Fam Pract; 1995 Aug; 41(2):126-36. PubMed ID: 7636452
    [Abstract] [Full Text] [Related]

  • 3. Rabeprazole versus ranitidine for the treatment of erosive gastroesophageal reflux disease: a double-blind, randomized clinical trial. Raberprazole Study Group.
    Farley A, Wruble LD, Humphries TJ.
    Am J Gastroenterol; 2000 Aug; 95(8):1894-9. PubMed ID: 10950032
    [Abstract] [Full Text] [Related]

  • 4. Management of heartburn in a large, randomized, community-based study: comparison of four therapeutic strategies.
    Howden CW, Henning JM, Huang B, Lukasik N, Freston JW.
    Am J Gastroenterol; 2001 Jun; 96(6):1704-10. PubMed ID: 11419818
    [Abstract] [Full Text] [Related]

  • 5. Ranitidine therapy for gastroesophageal reflux disease. Results of a large double-blind trial.
    Sontag S, Robinson M, McCallum RW, Barwick KW, Nardi R.
    Arch Intern Med; 1987 Aug; 147(8):1485-91. PubMed ID: 3307670
    [Abstract] [Full Text] [Related]

  • 6. Onset of relief of symptoms of gastroesophageal reflux disease: post hoc analysis of two previously published studies comparing pantoprazole 20 mg once daily with nizatidine or ranitidine 150 mg twice daily.
    Haag S, Holtmann G.
    Clin Ther; 2010 Apr; 32(4):678-90. PubMed ID: 20435237
    [Abstract] [Full Text] [Related]

  • 7. High- versus standard-dose ranitidine for control of heartburn in poorly responsive acid reflux disease: a prospective, controlled trial.
    Kahrilas PJ, Fennerty MB, Joelsson B.
    Am J Gastroenterol; 1999 Jan; 94(1):92-7. PubMed ID: 9934737
    [Abstract] [Full Text] [Related]

  • 8. On-demand treatment of acute heartburn with the antacid hydrotalcite compared with famotidine and placebo: randomized double-blind cross-over study.
    Holtmeier W, Holtmann G, Caspary WF, Weingärtner U.
    J Clin Gastroenterol; 2007 Jul; 41(6):564-70. PubMed ID: 17577112
    [Abstract] [Full Text] [Related]

  • 9. Cisapride 20 mg b.i.d. provides symptomatic relief of heartburn and related symptoms of chronic mild to moderate gastroesophageal reflux disease. CIS-USA-52 Investigator Group.
    Castell DO, Sigmund C, Patterson D, Lambert R, Hasner D, Clyde C, Zeldis JB.
    Am J Gastroenterol; 1998 Apr; 93(4):547-52. PubMed ID: 9576446
    [Abstract] [Full Text] [Related]

  • 10. [Comparison of the effects of Rocgel and anti-H2 on the symptomatology of gastroesophageal reflux without esophagitis].
    Houcke P, Maffioli C, Corallo J, Bouxin-Sauzet A, Martin AL.
    Ann Gastroenterol Hepatol (Paris); 1995 Sep; 31(4):264-7. PubMed ID: 7486823
    [Abstract] [Full Text] [Related]

  • 11. Cisapride compared with ranitidine in the treatment of functional dyspepsia.
    Carvalhinhos A, Fidalgo P, Freire A, Matos L.
    Eur J Gastroenterol Hepatol; 1995 May; 7(5):411-7. PubMed ID: 7614103
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Omeprazole versus high-dose ranitidine in mild gastroesophageal reflux disease: short- and long-term treatment. The Dutch Reflux Study Group.
    Festen HP, Schenk E, Tan G, Snel P, Nelis F.
    Am J Gastroenterol; 1999 Apr; 94(4):931-6. PubMed ID: 10201459
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Omeprazole 10 milligrams once daily, omeprazole 20 milligrams once daily, or ranitidine 150 milligrams twice daily, evaluated as initial therapy for the relief of symptoms of gastro-oesophageal reflux disease in general practice.
    Venables TL, Newland RD, Patel AC, Hole J, Wilcock C, Turbitt ML.
    Scand J Gastroenterol; 1997 Oct; 32(10):965-73. PubMed ID: 9361167
    [Abstract] [Full Text] [Related]

  • 16. Do endoscopic findings influence response to H2 antagonist therapy for gastroesophageal reflux disease?
    Robinson MG, Orr WC, McCallum R, Nardi R.
    Am J Gastroenterol; 1987 Jun; 82(6):519-22. PubMed ID: 3554990
    [Abstract] [Full Text] [Related]

  • 17. The effect of over-the-counter ranitidine 75 mg on night-time heartburn in patients with erosive oesophagitis on daily proton pump inhibitor maintenance therapy.
    Vakil N, Guda N, Partington S.
    Aliment Pharmacol Ther; 2006 Mar 01; 23(5):649-53. PubMed ID: 16480404
    [Abstract] [Full Text] [Related]

  • 18. Cimetidine in the treatment of symptomatic gastroesophageal reflux: a double blind controlled trial.
    Behar J, Brand DL, Brown FC, Castell DO, Cohen S, Crossley RJ, Pope CE, Winans CS.
    Gastroenterology; 1978 Feb 01; 74(2 Pt 2):441-8. PubMed ID: 340333
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Famotidine relieves symptoms of gastroesophageal reflux disease and heals erosions and ulcerations. Results of a multicenter, placebo-controlled, dose-ranging study. USA Merck Gastroesophageal Reflux Disease Study Group.
    Sabesin SM, Berlin RG, Humphries TJ, Bradstreet DC, Walton-Bowen KL, Zaidi S.
    Arch Intern Med; 1991 Dec 01; 151(12):2394-400. PubMed ID: 1746996
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.